Patent · US Active

Certain chemical entities, compositions and methods

US8871768B2 · kind B2 · utility

22Cited by
39References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 17, 2013
Grant dateOct 28, 2014
Priority date—
Expiry dateMay 17, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.